Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bayer wins marketing approval for anticoagulant drug
EU marketing approval for Xarelto was received following a review of data from the extensive record clinical program that included three Phase III trials of Xarelto involving nearly
EU marketing approval for Xarelto was received following a review of data from the extensive record clinical program that included three Phase III trials of Xarelto involving nearly
In preclinical models of human breast cancer, Angiolix had a significant anticancer effect in vivo; this effect was enhanced when Angiolix was given in combination with conventional chemotherapy
Prior to his arrival at Cayenne, Mullen served as senior vice president of US sales & customer operations for Smith & Nephew Endoscopy where among his achievements was
The patent is important to the company’s optical biopsy technology because it provides protection in the areas of tissue surveillance, characterization, diagnosis and treatment. It is said to
Greg Brown, CEO of ImpediMed, said: “Metagenics has been an outstanding Australian partner using ImpediMed’s body composition analysis devices for several years. This expanded relationship makes sense in
Omnilab’s core business of supplying instrumentation, consumables and services is expected to complement VWR’s local expertise in chemicals, consumables and life science products. Manuel Brocke-Benz, senior vice president
The payment was triggered by the market launch of Rotarix in the US. Rotarix is marketed worldwide by GlaxoSmithKline. John Leone, a partner at Paul Capital Healthcare, said:
Under the terms of the agreement, Roche’s exclusive rights to sell and distribute the ProbeLibrary products are extended on a co-exclusive basis. In addition, Roche obtains co-exclusive rights
This compound originates from the work of Pharmaleads’s chief scientists, Bernard Roques and Marie-Claude Fournie-Zaluski, and is a dual inhibitor of both enzymes responsible for the rapid degradation
Transave has previously reported positive Phase II data on Arikace from a randomized, placebo-controlled, 15-center study conducted in Europe. The study demonstrated that Arikace, delivered once daily for